EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The optimal conditions of colony stimulating factor generation by endo toxic lipo poly saccharide and its ps derivative in mice


Journal of Immunopharmacology 5(1-2): 93-106
The optimal conditions of colony stimulating factor generation by endo toxic lipo poly saccharide and its ps derivative in mice
Not only the endotoxic lipopolysaccharide (LPS) preparations, but a nontoxic, lipid-free, non-mitogenic hydrolytic breakdown product of it (called PS) is also capable of inducing colony stimulating factor (CSF) release. Due to difficulties in reproducing the above findings it became necessary to study the optimal conditions to obtain CSF active PS preparations. It was found that the CSF generating component of the highly heterogeneous PS mixture is sensitive to acidic hydrolyses, but it is less sensitive than the toxic site in the lipid moiety of the LPS. Carefully controlled optimal hydrolytic conditions give PS preparations which have < 1% residual endotoxicity but maintain 40-80% of the original CSF generating capacity. Prolonged hydrolysis will destroy this activity too. Optimal dose of LPS and PS for CSF induction in mice differed widely. For LPS the optimal dose is 25 .mu.g, injecting more gave a much reduced or nondetectable CSF level. Optimal dose for PS was 160 .mu.g, and this generated a significantly higher CSF level than 25 .mu.g LPS. At concentrations below 25 .mu.g, LPS was clearly more active than PS. The CSF level reached its peak at 3-4 h after the other LPS or PS injection. The i.v. route was sometimes but not always more effective than the i.p. route.


Accession: 006728564



Related references

Endo toxin lipo poly saccharide stimulates in vitro migration of macrophages from lipo poly saccharide resistant mice but not from lipo poly saccharide sensitive mice. Journal of Immunology 128(2): 608-613, 1982

Interactions of the complement system with endo toxic lipo poly saccharide generation of a factor chemotactic for polymorphonuclear leukocytes mouse. Journal of Experimental Medicine 128(2): 259-275, 1968

Serum of lipo poly saccharide treated mice contains 2 types of colony stimulating factor separable by affinity chromatography. Journal of Cellular Physiology 102(1): 1-10, 1980

Lipo poly saccharide regulation of the immune response bacteroides endo toxin induces mitogenic poly clonal and antibody responses in classical lipo poly saccharide responsive but not c 3h hej mice. Journal of Immunology 133(1): 299-305, 1984

Regulation of lipo poly saccharide induced granulopoiesis and macrophage formation by spleen cells 2. macrophage lymphocyte interactions in the process of generation of colony stimulating factor. Journal of Immunology 124(3): 1223-1229, 1980

Interactions of the complement system with endo toxic lipo poly saccharide the generation of an anaphyla toxin guinea pig serum. Immunology 16(3): 327-336, 1969

Colony stimulating factor release from quiescent fibroblasts is lipo poly saccharide inducible. Experimental Hematology (Charlottesville) 11(SUPPL 14): 229, 1983

Lipo poly saccharide inhibits the binding of colony stimulating factor to murine peritoneal exudate macrophages. Journal of Immunology 130(5): 2256-2260, 1983

Induction of phenotypic lymphocyte differentiation in lipo poly saccharide unresponsive mice by an lipo poly saccharide induced serum factor and by lipid a associated protein. Journal of Immunology 118(5): 1910-1911, 1977

Involvement of murine spleen cells in tolerance to lipo poly saccharide induced serum colony stimulating factor. Experimental Hematology (Charlottesville) 9(SUPPL 9): 9, 1981